CICLOPIROX OLAMINE
Generic: CICLOPIROX OLAMINE
Padagis Israel Pharmaceuticals LtdManufacturer
TOPICALRoute
CICLOPIROX OLAMINEActive Substance
2006-12-15Original Approval
CICLOPIROX OLAMINE is FDA application ANDA077676, sponsored by PADAGIS ISRAEL. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2018-01-19
Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15); b) 30 g tubes (NDC 0713-0638-31); andDiscoloration: Product is supposed to be a white to off white homogenous cream and may have intermit
Class III2017-03-20
Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15), b) 30 g tubes (NDC 0713-0638-31), andLabeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert.
Top Reported Reactions
1
DRUG INEFFECTIVE
140 reports
2
DEVICE DISLOCATION
79 reports
3
DEVICE MALFUNCTION
79 reports
4
PRODUCT USE IN UNAPPROVED INDICATION
38 reports
5
RASH
26 reports
6
OFF LABEL USE
25 reports
7
FATIGUE
23 reports
8
PRURITUS
21 reports
9
CONDITION AGGRAVATED
17 reports
10
PAIN
17 reports